UnknownPhase 1

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Lead sponsor

First Affiliated Hospital of Fujian Medical University

Asset

Exenatide

GLP-1 agonist

Listed sites

Recruiting sites

Estimated enrollment

Study population

Oncology

Eligibility highlights

Primary endpoint

•Standard uptake value (SUV)

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT04979611

Org study IDFirstAHFujian11

Timeline

Milestones

Study start2020-08-01actual

Study first posted2021-07-28actual

Last update posted2023-09-21actual

Primary completion2025-08-01estimated

Study completion2025-08-01estimated

Assets

Investigational agents

Exenatide

Who this study enrolls

Oncology

Who can enroll

Minimum age6 Years

Maximum age70 Years

SexAll

Healthy volunteersNot accepted

Inclusion criteria

•1.age ≥6 years old 2.Patients with hypoglycaemia 3.Endogenous hyperinsulinemic hypoglycaemia 4.Enhanced CT or MRI within 1 month 5.Signed written consent

Exclusion criteria

•1. Breast feeding 2.Pregnancy or the wish to become pregnant within 6 months 3.Renal function: serum creatinine during 41-73umol/L 4.Any medical condition may significantly interfere with study compliance; 5.Known allergy

Endpoints (1)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other (unclassified)

1 endpoint

Primary/protocol endpoint/low confidence

Standard uptake value (SUV)

Time frame:From right after tracer injection to 1-hours post-injection

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.